Research Roundup: Use of Generic Drugs Reduces Costs of AIDS Relief
July 13, 2012
Since its inception nearly a decade ago, a US program for supplying AIDS medications to the developing world has grown significantly. Meanwhile, costs of treatment per patient have dramatically fallen. The primary reason? The increasing availability of generic antiretroviral drugs, according to a review article published in the July issue of Health Affairs. The President's Emergency Plan for AIDS Relief (PEPFAR) was set up in 2003 with the aim of supporting prevention, treatment, and care efforts in 15 focus countries in the developing world (Fox, Medscape, 7/9).
Trade Agreements Could Harm Access to Antiretroviral Drugs in Asia, Pacific, Experts and Activists Warn
Growing Number of Countries Adopting Flexible Intellectual Property Regulations After India Issues Country's First Compulsory License
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)